Nitto Denko And Quark Pharmaceuticals Sign siRNA Drugs Collaboration Agreement
This article was originally published in PharmAsia News
Executive Summary
Osaka-based Nitto Denko and California-based Quark Pharmaceuticals formed a collaboration to develop small interfering RNA drugs for fibrotic diseases